The stock's fall snapped a three-day winning streak.

In the assessment of 12-month price targets, analysts unveil insights for Raymond James Finl, presenting an average target of $159.4, a high estimate of $175.00, and a low estimate of $143.00.

Fintel reports that on July 11, 2025, Raymond James initiated coverage of Vir Biotechnology (NasdaqGS:VIR) with a Outperform ...

Fintel reports that on July 11, 2025, Raymond James initiated coverage of Janux Therapeutics (NasdaqGM:JANX) with a ...

Wells Fargo & Company (NYSE:WFC) is one of the 13 stocks recently discussed by Jim Cramer. Coming to the company, Cramer commented: “Finally, Raymond James downgraded Wells Fargo, another Charitable ...

Robinson will depart from his roles as president and CFO of the company and subsidiary MVB Bank, effective Monday, said MVB. He will be available throughout the next year to provide continued ...

Erlanger announced the appointment of two new members to its board of directors. Additional updates for this fiscal year ...

Robert D. Kendall brings decades of experience, including roles at DWS Americas and a former investment unit within Morgan ...

US President Donald Trump on Wednesday threatened Brazil with a crippling tariff of 50% starting August 1, according to a ...

Citadel Advisor's Ken Griffin bought over 9.1 million shares of the Alignment Healthcare stock days before the tech-enabled ...